Friman S - Search Results

1

Is a 3-day waiting list appropriate for patients with acute liver failure?

Höckerstedt K, Isoniemi H, Ericzon BG, Broomé U, Friman S, Persson H, Bergan A, Schrumpf E, Kirkegaard P, Hjortrup A, et al. Höckerstedt K, et al. Among authors: friman s. Transplant Proc. 1994 Jun;26(3):1786-7. Transplant Proc. 1994. PMID: 8030134 No abstract available.

2

Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?

Bjøro K, Kirkegaard P, Ericzon BG, Friman S, Schrumpf E, Isoniemi H, Herlenius G, Olausson M, Rasmussen A, Foss A, Höckerstedt K. Bjøro K, et al. Among authors: friman s. Transplant Proc. 2001 Jun;33(4):2511-3. doi: 10.1016/s0041-1345(01)02080-2. Transplant Proc. 2001. PMID: 11406230 No abstract available.

3

Time to request ABO-identity when transplanting for fulminant hepatic failure?

Ericzon BG, Bjoro K, Hoeckerstedt K, Hanssen B, Olausson M, Isoniemi H, Kirkegaard P, Soderdahl G, Foss A, Friman S. Ericzon BG, et al. Among authors: friman s. Transplant Proc. 2001 Nov-Dec;33(7-8):3466-7. doi: 10.1016/s0041-1345(01)02493-9. Transplant Proc. 2001. PMID: 11750483 No abstract available.

4

Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.

Brandsaeter B, Broomé U, Isoniemi H, Friman S, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Olsson R, Olausson M, Kirkegaard P, Bjøro K. Brandsaeter B, et al. Among authors: friman s. Liver Transpl. 2003 Sep;9(9):961-9. doi: 10.1053/jlts.2003.50169. Liver Transpl. 2003. PMID: 12942458 Free article.

5

Ursodeoxycholic acid reduces acute rejection in heart allografted rats.

Friman S, Mjörnstedt L, Persson H, Karlberg I, Olausson M. Friman S, et al. Transplant Proc. 1992 Feb;24(1):344-5. Transplant Proc. 1992. PMID: 1539308 No abstract available.

6

Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.

Friman S, Persson H, Scherstén T, Svanvik J, Karlberg I. Friman S, et al. Transplant Proc. 1992 Feb;24(1):389-90. Transplant Proc. 1992. PMID: 1539328 Clinical Trial. No abstract available.

7

The bile-acid-independent flow is reduced in the transplanted liver.

Friman S, Persson H, Karlberg I, Svanvik J. Friman S, et al. Transplant Proc. 1992 Feb;24(1):396-7. Transplant Proc. 1992. PMID: 1539332 No abstract available.

8

Adjuvant ursodeoxycholic acid prevents acute rejection in liver transplant recipients.

Henriksson BA, Persson H, Friman S, Wängberg B, Svanvik J, Karlberg I. Henriksson BA, et al. Among authors: friman s. Transplant Proc. 1991 Jun;23(3):1971. Transplant Proc. 1991. PMID: 2063453 No abstract available.

9

Liver transplantation halts the progress of familial amyloidotic polyneuropathy.

Ericzon BG, Suhr O, Broomé U, Holmgren G, Duraj F, Eleborg L, Wikström L, Norden G, Friman S, Groth CG. Ericzon BG, et al. Among authors: friman s. Transplant Proc. 1995 Feb;27(1):1233. Transplant Proc. 1995. PMID: 7878861 Clinical Trial. No abstract available.

10

Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation.

Bjøro K, Ericzon BG, Kirkegaard P, Höckerstedt K, Söderdahl G, Olausson M, Foss A, Schmidt LE, Isoniemi H, Brandsaeter B, Friman S. Bjøro K, et al. Among authors: friman s. Transplantation. 2003 Feb 15;75(3):347-53. doi: 10.1097/01.TP.0000044359.72379.E5. Transplantation. 2003. PMID: 12589157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page